
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.31, moving 1.6% from the previous trading session.
Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
| Revenue (TTM) | $858.27M |
| Gross Profit (TTM) | $237.55M |
| EBITDA | $17.76M |
| Operating Margin | -52.70% |
| Return on Equity | -63.20% |
| Return on Assets | -1.47% |
| Revenue/Share (TTM) | $8.04 |
| Book Value | $3.02 |
| Price-to-Book | 0.37 |
| Price-to-Sales (TTM) | 0.62 |
| EV/Revenue | 0.779 |
| EV/EBITDA | -4.84 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.80% |
| Shares Outstanding | $123.46M |
| Float | $444.06M |
| % Insiders | 0.71% |
| % Institutions | 9.37% |
Volatility is currently expanding

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.31, moving 1.6% from the previous trading session.

Tilray's business has gotten bigger over the years, but that's largely due to acquisitions. The company continues to struggle with profitability.

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

Tilray hopes that several ongoing developments will help it rebound. But the company's outlook remains highly uncertain.

Tilray expands its medical cannabis strategy with HelloMD, adding virtual patient access as investors weigh growth potential against ongoing profitability challenges.

Although the growth rates coming out of the quantum computing segment look genuinely spectacular on paper, Wall Street has stood on this exact ledge before, and the fall has never been gentle.

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $4.43, representing a -1.34% change from its previous close.

While cannabis investors finally have an expedited DEA administrative hearing on the calendar and a fresh Schedule III pathway in motion, Wall Street has stood at this exact intersection before.

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Tilray Beer, the fourth largest craft brewer in the U.S. and the beer division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is tapping into Fourth of July weekend with a coast-to-coast lineup of craft beer celebrations that capture the energy, pride and American spirit of the holiday. What better way to celebrate America's 250th birthday than with great craft beer, live music, fireworks, BBQ favorites, red, white and blue cocktails, exclusive merch, patio games and cooler-ready to-go beer deals at Tilray Beer taprooms across the country.

Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada